Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule.
The Food and Drug Administration (FDA) is issuing a final rule amending the monograph for over-the-counter (OTC) topical antifungal drug products. The amendment makes a minor change in the indications for these drug products. This final rule is part of the ongoing review of OTC drug products conducted by FDA.
D000287:Administration, Topical; D000935:Antifungal Agents / Q000493:pharmacokinetics*; D006801:Humans; D004366:Nonprescription Drugs / Q000493:pharmacokinetics; D011356:Product Labeling / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration
D000935:Antifungal Agents; D004366:Nonprescription Drugs